Smita S. Chandran

TOX is a critical regulator of tumour-specific T cell differentiation

Andrew Scott, Friederike Dündar, Paul Zumbo et al. · Nature · 2019 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +14

Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study

Smita S. Chandran, Robert Somerville, James C. Yang et al. · The Lancet Oncology · 2017 · 288 citations

Medicine, Immunology, Oncology +16

Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy

Christopher A. Klebanoff, Joseph G. Crompton, Anthony Leonardi et al. · JCI Insight · 2017 · 222 citations · Full text

Life Sciences, Cancer Biology, Immunology +17

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

Smita S. Chandran, Jiaqi Ma, Martin G. Klatt et al. · Nature Medicine · 2022 · 129 citations · Full text

Life Sciences, Immunology, Oncology +17

CTLA4 Expression Is an Indicator and Regulator of Steady-State CD4+FoxP3+ T Cell Homeostasis

Anita L. Tang, John R. Teijaro, Modesta N. Njau et al. · The Journal of Immunology · 2008 · 116 citations · Full text

Life Sciences, Cell Biology, Immunology +17